Voyager Announces CEO Succession Plan, Appoints Robin Swartz President
Voyager Therapeutics' board appointed Robin Swartz, currently Chief Business and Operating Officer, as President effective October 20, 2026, with a plan for her to succeed Alfred W. Sandrock, Jr. as CEO in Q1 2027. The transition is tied to a key pipeline milestone: Dr.
Key figures
- Succession timing
- Q1 2027
- President effective date
- October 20, 2026
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.